Diabetes Medications on Medicare: GLP-1s, SGLT2s, and More

Diabetes medication has changed dramatically in the last decade, and Medicare coverage has had to keep up. The newer drug classes, especially GLP-1 receptor agonists and SGLT2 inhibitors, treat type 2 diabetes while also helping with heart and kidney health, which is why so many people are on them. But coverage comes with an important twist that trips people up constantly: whether a drug is covered can depend on why it was prescribed, not just what the drug is. Understanding that distinction, along with the $35 insulin cap and how Part D handles these drugs, can save you a great deal of money and confusion.

Bryce's Take

The diabetes conversation almost always comes back to two things: the GLP-1 and weight-loss confusion, and insulin cost. On the first, I tell clients plainly that coverage can depend on why the drug was prescribed, so we check the specific plan rather than assuming. On insulin, the $35-per-month cap is a genuine relief for people who used to pay far more. If you are managing diabetes, bring me your full medication list and we will find the plan that covers all of it for the least.

How diabetes drugs are covered under Part D

Prescription diabetes medications you take yourself, whether oral pills or self-injected drugs, are covered under Medicare Part D. That includes the older drugs like metformin, the sulfonylureas, and the newer classes discussed below. As always with Part D, your specific cost depends on your plan's formulary tier and cost-sharing, so the same drug can cost different amounts on different plans. Insulin, which we cover separately below, has its own special protection.

GLP-1 drugs for diabetes: Ozempic, Trulicity, Mounjaro

GLP-1 receptor agonists, including Ozempic, Trulicity, and Mounjaro, are widely prescribed for type 2 diabetes and are covered by Part D when prescribed to treat diabetes. They tend to sit on higher formulary tiers, so cost-sharing can be significant before you reach the annual cap. These drugs have become extremely popular in part because of their effect on weight, which leads directly to the most important nuance in diabetes coverage.

The weight-loss coverage nuance you must understand

Here is where people get caught. The same active ingredient can be sold under different brand names for different purposes. When one of these drugs is prescribed to treat type 2 diabetes, Part D generally covers it. But when a version is prescribed purely for weight loss, for example Wegovy, Part D has historically not covered it for weight loss alone, because a longstanding rule excluded weight-loss drugs from Part D. This area is evolving, and there are narrow, developing exceptions where a drug may be covered for a related condition rather than weight loss by itself. The practical takeaway is that coverage can hinge on the diagnosis your doctor documents, so if you are counting on coverage, confirm it against your specific plan rather than assuming.

SGLT2 inhibitors: Jardiance and Farxiga

SGLT2 inhibitors, including Jardiance and Farxiga, are another major class for type 2 diabetes, and both also carry approvals for heart failure and, in Farxiga's case, chronic kidney disease. Both are covered under Part D, and notably both are on the first list of Medicare negotiated drugs, with lower prices taking effect January 1, 2026. As with the GLP-1s, your actual cost depends on your plan's formulary placement.

Managing diabetes and want the best drug coverage?

Diabetes usually means multiple medications, and the right plan is the one that covers all of yours at good tiers. Let me compare plans on your exact drug list, including your insulin, and find your lowest total cost.

Book a Free Call

The $35 insulin cap

If you use insulin, Medicare limits your cost-sharing to no more than $35 per month for each covered insulin product. This cap applies across Part D plans and to insulin used with covered pumps under Part B, so it protects you regardless of which insulin you use, as long as it is covered by your plan. This is one of the clearest, most valuable protections in Medicare drug coverage, and it applies from the very first fill, with no deductible to clear first for the insulin.

Choosing a plan when you have diabetes

Because diabetes often means several medications, the right Part D or Medicare Advantage drug plan is the one that covers your specific drugs at good tiers. During the Annual Enrollment Period, compare plans on your full medication list, including your exact GLP-1 or SGLT2 drug and your insulin. Factor in the $35 insulin cap and the $2,000 annual out-of-pocket cap that began in 2025. If your diabetes drugs are expensive, this comparison is where real savings show up, and it is exactly what a call with me is for.

Frequently asked questions

Does Medicare cover Ozempic and Mounjaro?

Yes, when prescribed to treat type 2 diabetes, Part D generally covers GLP-1 drugs like Ozempic, Trulicity, and Mounjaro. They tend to sit on higher formulary tiers, so cost-sharing depends on your specific plan. Coverage can differ if a version is prescribed for weight loss alone.

Does Medicare cover Wegovy for weight loss?

Historically Part D has not covered drugs prescribed purely for weight loss, such as Wegovy for weight loss alone, because of a longstanding exclusion. This area is evolving with narrow developing exceptions tied to related conditions. Coverage can depend on the documented diagnosis, so confirm it against your specific plan.

Are Jardiance and Farxiga covered by Medicare?

Yes. These SGLT2 inhibitors are covered under Part D for type 2 diabetes, and both also carry heart and kidney approvals. Both are on the first Medicare negotiated drug list, with lower prices taking effect January 1, 2026. Your cost depends on your plan's formulary.

How much does insulin cost on Medicare?

Medicare caps your cost-sharing at no more than $35 per month for each covered insulin product, with no deductible to clear first for the insulin. The cap applies across Part D plans and to insulin used with covered pumps under Part B.

Do diabetes drugs count toward the $2,000 cap?

Yes. Covered Part D diabetes drugs count toward the $2,000 annual out-of-pocket cap that began in 2025. Once your combined covered drug cost-sharing reaches $2,000 in a plan year, you pay nothing more for covered drugs that year.

Bryce Casson

Licensed Independent Medicare Broker

Bryce Casson is an independent Medicare insurance broker who works with every major carrier. He does not represent any single insurer, which means his recommendations are based on what actually fits each client's situation, not on commissions or quotas.